EXPLANATORY FACTORS FOR NON-COMPLIANCE TO ANTI-RETRO VIRAL TREATMENT AMONG PEOPLE LIVING WITH HIV AND UNDER TREATMENT IN THE KARISIMBI HEALTH DISTRICT, IN THE DEMOCRATIC REPUBLIC OF CONGO
DOI:
https://doi.org/10.59296/tgjs.2441001Abstract
Introduction: Knowledge of the factors favorable to treatment compliance among patients suffering from HIV/AIDS remains a concern for all health professionals. This study aimed to determine the level of compliance with antiretroviral treatment (ART) and associated factors among people living with human immunodeficiency virus (PLHIV) treated in the Karisimbi health zone.
Methods: this was an analytical cross-sectional study carried out in the Karisimbi health zone from October 1 to December 31, 2021 with a simple probability sample of 384 people living with HIV under anti-retroviral treatment in the period from August 1, 2020 to September 30, 2021 in three target care structures in the health zone, North Kivu, in the Democratic Republic of Congo. The data were analyzed with SPSS 21.
Results: The prevalence of non-compliance with ARV treatment was 24.7%, the median age was 39 years (interquartile range of 7 years) and the female gender was the most represented (sex ratio: 3.5). The factors significantly associated with non-compliance were: home time – care structure (ORa: 1.7; 95% CI: 1.07 - 2.69); stigma (aOR: 1.6; 95% CI: 1.01 - 2.82); not belonging to a support group (ORa: 0.5; 95% CI: 0.27 - 0.94) and the use of an alternative treatment to ARVs (ORa: 2.3; 95% CI: 1 .30-4.09).
Conclusion: It appears in this study that the prevalence of non-compliance with anti-retroviral treatment in this health zone was high. We recommend promoting the education of PLHIV through therapeutic education sessions with a view to improving compliance with ARVs in order to reduce the risk of treatment failure.
Downloads
References
ONUSIDA, FICHE D'INFORMATION - JOURNEE MONDIALE DU SIDA 2021, https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_fr.pdf
Ministère de la sante RDC, DEUXIÈME ENQUÊTE DÉMOGRAPHIQUE ET DE SANTÉ (EDS-RDC II 2013-2014), https://www.unicef.org/drcongo/media/1046/file/EDS-RDC%20II%202013-2014.pdf,septembre 2014
ONUSIDA, Fiche d'information - Journée Mondiale du Sida 2021, https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_fr.pdf
ONUSIDA, 90–90–90 : de solides avancées, mais le monde est en retard pour atteindre les objectifs 2020, https://www.unaids.org/fr/90-90-90#:~:text=Les%20objectifs%2090%2D90%2D90,traitement%20antir%C3%A9troviral%20voient%20leur%20charge
Médecins Sans Frontières, Rapport international d’activités 2019, République Démocratique du Congo. https://www.msf.org/fr/rapport-international-dactivit%C3%A9s-2019/r%C3%A9publique-d%C3%A9mocratique-du-congo
Ministère de la Santé Publique (RD Congo), Plan National De Développement Sanitaire (PNDS) 2011-2015, Mars 2010
Frédérique Muller, Les déterminants non biologiques de l’échec thérapeutique chez les PVVIH sous ARV depuis 10 ans au Sénégal, étude qualitative exploratoire, Journée scientifique ANRS Dakar Juin 2010
Solthis, Traitement Antiretroviral du VIH : situation de la deuxième ligne en Afrique, Journée scientifique Solthis Juin 2012
Mahy S. et al., Mesure de l'efficacité et le respect de la thérapie l’antirétrovirale chez les patients infectés par le VIH au Cameroun, Avril 2011
Denis Fompeyrine, L’observance des traitements : un défi aux politiques de santé, Fondation Concorde, Mars 2014 .pp 6
François-Xavier Mbopi-Kéou, Lucienne Dempouo Djomassi, et Francisca Monebenimp, Etude des facteurs liés à l'observance au traitement antirétroviral chez les patients suivis à l'Unité de Prise En Charge du VIH/SIDA de l'Hôpital de District de Dschang, Cameroun, The Pan African Medical Journal, v.12; 2012
Christian Mouala, Joachim Kaba-Mebri, Jean-Bertrand Wata, Jean-Loup Rey, Facteurs associés à une bonne observance thérapeutique chez les patients infectés par le VIH à Bangui, Cahiers d'études et de recherches francophones / Santé ,Volume 16, numéro 2, Avril-Mai-Juin 2006
Shigdel R, Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal, HIV/AIDS (Auckland, N.Z.).2014 Jun 24; 6:109-16.
Oku AO et al., Prevalence and determinants of adherence to highly active antiretroviral therapy amongst people living with HIV/AIDS in a rural setting in south-south Nigeria, African Journal of Reproduction Health.2014 Mar; 18(1):133-43.
Denison JA et al. , Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia, AIDS.2015 Jan 28; 29(3):361-71).
Sanjobo N , Frich JC , Fretheim A . Sanjobo font N , Frich JC , Fretheim A , Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia : a qualitative study, SAHARA Journal,2008 Sep;5(3):136-43
Alemayehu Amberbir et al., Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia, Bio Medical Center Public Health 2008. 2014 Nov. 25;17:19227
Oumar AA et al., Les Facteurs associés à l’observance du traitement antirétroviral à l’hôpital du Point G, Mali Médical 2007 T XXII N° 1
Daniel Nyogea et al., Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study, Biomedical Center of Infection Diseases vol.15;2015
Patou Masika Musumari , Patrick Kalambayi K. et al., Food Insecurity Is Associated with Increased Risk of Non-Adherence to Antiretroviral Therapy among HIV-Infected Adults in the Democratic Republic of Congo: A Cross-Sectional Study, PLoS One. 2014; 9(1).
Edward J Mills et al., Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators, PLoS Med. 2006 Nov, Published online 2006 Nov 21. doi: 10.1371/journal.pmed.0030438
Negash T , Ehlers V . Negash T , V Ehlers, Personal factors influencing patients' adherence to ART in Addis Ababa, Ethiopia, J Assoc Nurses AIDS Care.2013 Nov-Dec;24(6):530-8.
Abush Kebede Ketema et Zewdu Shewangizaw Weret, Assessment of adherence to highly active antiretroviral therapy and associated factors among people living with HIV at Debrebrihan Referral Hospital and Health Center, Northeast Ethiopia: a cross-sectional study, HIV AIDS research and palliative care (Auckland). 2015; 7: 75–81)
Uzochukwu BS et al, Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria, Health Policy and Planning, 2009 May; 24(3):189-96)
Karina M Berg et al., Gender Differences in Factors Associated with Adherence to Antiretroviral Therapy, Journal of General Internal Medecine. 2004 November; 19(11): 1111–1117.
Jean-Paul Moatti, Les enjeux économiques et sociaux de l’infection par le VIH à l’ère des multithérapies antirétrovirales, Apports des sciences humaines et sociales, médecine sciences, Volume 19, numéro 8-9, août-septembre 2003, p. 878-884
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 MATIABA BINDA Paul, WEMBONYAMA OKITOSHO Stanis
This work is licensed under a Creative Commons Attribution 4.0 International License.
